Zeting Yuan

1.3k total citations
31 papers, 1.0k citations indexed

About

Zeting Yuan is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Zeting Yuan has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Biomedical Engineering and 9 papers in Oncology. Recurrent topics in Zeting Yuan's work include Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Zeting Yuan is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Zeting Yuan collaborates with scholars based in China, United States and France. Zeting Yuan's co-authors include Peihao Yin, Feng Gao, Ke Xu, Yanyan Qiu, Yueping Zhan, Guohua Fan, Minbo Lan, Xin Liang, Huihui Yuan and Yijun Cao and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Controlled Release and British Journal of Cancer.

In The Last Decade

Zeting Yuan

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeting Yuan China 18 411 275 238 200 194 31 1.0k
Xin Wei United States 18 579 1.4× 363 1.3× 336 1.4× 339 1.7× 128 0.7× 47 1.5k
Amit Singh Yadav India 18 528 1.3× 275 1.0× 225 0.9× 216 1.1× 194 1.0× 40 1.3k
Jingxin Mo China 19 361 0.9× 241 0.9× 250 1.1× 193 1.0× 94 0.5× 31 903
Hui Xiong China 23 615 1.5× 539 2.0× 389 1.6× 177 0.9× 248 1.3× 55 1.4k
Ruoning Wang China 24 774 1.9× 449 1.6× 406 1.7× 116 0.6× 215 1.1× 48 1.5k
Jiemin Wang China 22 907 2.2× 261 0.9× 137 0.6× 162 0.8× 386 2.0× 66 1.5k
Prasanthi Karna United States 16 629 1.5× 132 0.5× 143 0.6× 214 1.1× 255 1.3× 21 1.2k
Jijun Fu China 23 504 1.2× 494 1.8× 343 1.4× 83 0.4× 132 0.7× 58 1.4k
Yun Luo China 17 392 1.0× 248 0.9× 235 1.0× 125 0.6× 114 0.6× 44 1.1k

Countries citing papers authored by Zeting Yuan

Since Specialization
Citations

This map shows the geographic impact of Zeting Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeting Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeting Yuan more than expected).

Fields of papers citing papers by Zeting Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeting Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeting Yuan. The network helps show where Zeting Yuan may publish in the future.

Co-authorship network of co-authors of Zeting Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Zeting Yuan. A scholar is included among the top collaborators of Zeting Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeting Yuan. Zeting Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ouyang, Ming, Xi Yu, Jun Zhong, et al.. (2025). Injectable sodium alginate/4-arm polyethylene glycol-lipoic acid double-network hydrogel loading Ca2+-tannic acid nanocomposite treats periodontitis via anti-bacteria, ROS scavenging and osteogenesis. International Journal of Biological Macromolecules. 307(Pt 1). 141841–141841. 1 indexed citations
2.
3.
Yi, Cheng, Jiafeng Zou, Muye He, et al.. (2024). Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy. Journal of Controlled Release. 367. 167–183. 13 indexed citations
4.
Xi, Yu, et al.. (2024). New horizons in the mechanisms and therapeutic strategies for PD-L1 protein degradation in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(5). 189152–189152. 6 indexed citations
5.
Zou, Jiafeng, Muye He, You Chen, et al.. (2023). Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition. ACS Applied Materials & Interfaces. 15(46). 53198–53216. 3 indexed citations
6.
Yuan, Zeting, Hai He, Jiafeng Zou, et al.. (2023). Polydopamine-coated ferric oxide nanoparticles for R848 delivery for photothermal immunotherapy in breast cancer. International Journal of Pharmaceutics. 644. 123249–123249. 9 indexed citations
7.
8.
Zou, Jiafeng, Zeting Yuan, Xiaojie Chen, et al.. (2023). Hydrogen sulfide responsive nanoplatforms: Novel gas responsive drug delivery carriers for biomedical applications. Asian Journal of Pharmaceutical Sciences. 19(1). 100858–100858. 14 indexed citations
9.
He, Muye, Yi An Cheng, Jie Wang, et al.. (2023). Spatiotemporally controllable diphtherin transgene system and neoantigen immunotherapy. Journal of Controlled Release. 355. 538–551. 6 indexed citations
10.
Yuan, Zeting, Yue Li, Honglei Wu, et al.. (2022). Bufalin exacerbates Photodynamic therapy of colorectal cancer by targeting SRC-3/HIF-1α pathway. International Journal of Pharmaceutics. 624. 122018–122018. 25 indexed citations
11.
Yuan, Zeting, Guohua Fan, Honglei Wu, et al.. (2021). Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles. Molecular Therapy. 29(10). 2931–2948. 103 indexed citations
12.
Chen, Jinbao, Haijing Wang, Linlin Jia, et al.. (2021). Bufalin targets the SRC-3/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer. Cancer Letters. 513. 63–74. 43 indexed citations
13.
Hou, Xinyu, Muye He, Jiajun Xu, et al.. (2020). A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy. Acta Pharmaceutica Sinica B. 10(9). 1741–1753. 22 indexed citations
14.
Xu, Jiajun, Muye He, Xinyu Hou, et al.. (2019). Safe and Efficacious Diphtheria Toxin-Based Treatment for Melanoma: Combination of a Light-On Gene-Expression System and Nanotechnology. Molecular Pharmaceutics. 17(1). 301–315. 5 indexed citations
15.
Yuan, Zeting, Guohua Fan, Hong Wang, et al.. (2019). <p>cRGD-Conjugated Fe<sub>3</sub>O<sub>4</sub>@PDA-DOX Multifunctional Nanocomposites for MRI and Antitumor Chemo-Photothermal Therapy</p>. International Journal of Nanomedicine. Volume 14. 9631–9645. 46 indexed citations
16.
Xu, Ke, Yueping Zhan, Zeting Yuan, et al.. (2019). Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop. Molecular Therapy. 27(10). 1810–1824. 129 indexed citations
17.
Yuan, Zeting, Yuxia Yuan, Lin Han, et al.. (2018). Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer. International Journal of Nanomedicine. Volume 13. 7533–7548. 33 indexed citations
18.
Yuan, Zeting, Yanyan Qiu, Tingting Jia, et al.. (2017). Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin. Oncology Reports. 37(3). 1815–1825. 54 indexed citations
19.
Chen, Yanzuo, et al.. (2017). Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy. Molecular Pharmaceutics. 14(4). 1190–1203. 44 indexed citations
20.
Yuan, Zeting, Ya‐Jing Ye, Feng Gao, et al.. (2013). Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release. International Journal of Pharmaceutics. 446(1-2). 191–198. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Wei Breakdown of academic impact, for papers by Amit Singh Yadav Breakdown of academic impact, for papers by Jingxin Mo Breakdown of academic impact, for papers by Hui Xiong Breakdown of academic impact, for papers by Ruoning Wang Breakdown of academic impact, for papers by Jiemin Wang Breakdown of academic impact, for papers by Prasanthi Karna Breakdown of academic impact, for papers by Jijun Fu Breakdown of academic impact, for papers by Yun Luo
Rankless by CCL
2026